Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R6KV
|
||||
| Drug Name |
moexiprilat
|
||||
| Synonyms |
103775-14-0; moexiprilat
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Unspecified | Investigative | [1], [2] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C25H30N2O7
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Angiotensin-converting enzyme | Target Info | Modulator | [1] | |
| KEGG Pathway | Renin-angiotensin system | ||||
| Chagas disease (American trypanosomiasis) | |||||
| Hypertrophic cardiomyopathy (HCM) | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | ||||
| WikiPathways | ACE Inhibitor Pathway | ||||
| Metabolism of Angiotensinogen to Angiotensins | |||||
| References | |||||
| REF 1 | Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther. 1995 Nov;275(2):854-63. | ||||
| REF 2 | Pharmacological and clinical profile of moexipril: a concise review.J Clin Pharmacol.2004 Aug;44(8):827-36. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.